A Race For Better Gene Editing Tech Is On
A transformative technology for gene editing - clustered regularly interspaced short palindromic repeats (CRISPR) -- has become ubiquitous, at least …
Industry Trends
Is Pharma Ready For Serialization? The Answer Lies In Digital Technology
New legislation requiring pharmaceutical companies to implement 'serialization' is now coming into force. This means that no counterfeit product should …
Challenges of IP Law In The Era of Artificial Intelligence in Healthcare
Artificial intelligence continues to expand into more aspects of human life on a weekly basis. The field is no longer …
FDA Analysis of Antibiotic Development - with Hubris!
(This post originally appeared on David Shlaes's personal blog) The US FDA just published an analysis of antibiotic development looking back …
Democratizing Early Drug Discovery through Artificial Intelligence: Interview with Syntekabio CEO Jongsun Jung
Before the age of modern drug discovery, the pharmaceutical industry had been plagued with uncertainty and processing challenges, including the …
Will 2019 Bring Positive Signals for the Declining Antibiotics R&D Market?
Antibiotic R&D has had a particularly bad year starting with The Medicines Company who abandoned their antibiotic R&D efforts and …
The Increasing Potential of Virtual Reality in Drug Design
Using virtual reality (VR) for manipulating 3D models of molecules in the context of drug design is an emerging technological …
Powered by Venture Funding, the Microbiome Market is Ready for Mainstream
2020 was an unusual year, for the first time, venture funding for microbiome companies substantially exceeded grant funding for microbiome …
Microbiome: Can Human Microbes Become A Panacea?
The microbiome is implicated in a number of metabolic pathways and communicates closely with our body in health and diseases. …
![[Interview] Shaping European Life Sciences with …](/files/blog/20200501_150827.1365_loubna-okra.jpg)
[Interview] Shaping European Life Sciences with AI
There is a great deal of hype and a lot of misconceptions among life science experts as to how AI …
Next-Generation Sequencing Is The Next Big Thing In Pharmacogenomics
Pharmacogenomics seeks to understand underlying genetic markers that influence treatment responses and modification of therapies to increase efficacy treatment success …
Hunting Dark Genes For Druggable Targets
About one in three human proteins is understudied. Even when quantifying data is available from multiple sources, "dark" genes and proteins …
